desoxycorticosterone acetate has been researched along with Cardiac Diseases in 4 studies
Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypertension was induced by deoxycorticosterone acetate (DOCA)-salt administration in uninephrectomized rats for 6 weeks." | 1.51 | Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Functional and Structural Changes. ( Bal, NB; Demirel-Yilmaz, E; Han, S; Kiremitci, S; Sadi, G; Uludag, O; Usanmaz, SE, 2019) |
| "Spironolactone treatment prevented Th17 cell activation and increased numbers of forkhead box P3-positive cells relative to DOCA-salt rats." | 1.40 | Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. ( Alzamora, R; Amador, CA; Barrientos, V; Carrasco, L; Figueroa, F; González, M; Herrada, AA; Kalergis, AM; Michea, L; Peña, J; Valdés, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bal, NB | 1 |
| Han, S | 1 |
| Usanmaz, SE | 1 |
| Kiremitci, S | 1 |
| Sadi, G | 1 |
| Uludag, O | 1 |
| Demirel-Yilmaz, E | 1 |
| Lee, JY | 1 |
| Tobian, L | 1 |
| Amador, CA | 1 |
| Barrientos, V | 1 |
| Peña, J | 1 |
| Herrada, AA | 1 |
| González, M | 1 |
| Valdés, S | 1 |
| Carrasco, L | 1 |
| Alzamora, R | 1 |
| Figueroa, F | 1 |
| Kalergis, AM | 1 |
| Michea, L | 1 |
| MIRCOLI, D | 1 |
| CAZZOLA, R | 1 |
4 other studies available for desoxycorticosterone acetate and Cardiac Diseases
| Article | Year |
|---|---|
Activation of Liver X Receptors by GW3965 Attenuated Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Functional and Structural Changes.
Topics: Animals; Apoptosis; Benzoates; Benzylamines; Blood Pressure; Desoxycorticosterone Acetate; Disease M | 2019 |
Cerebral aqueduct block attenuates cardio-renal injuries in post-DOCA-NaCl-hypertensive Dahl R rats.
Topics: Animals; Cerebral Aqueduct; Desoxycorticosterone Acetate; Heart Diseases; Hypertension; Kidney Disea | 2013 |
Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
Topics: Animals; Antibodies; Desoxycorticosterone Acetate; Disease Models, Animal; Down-Regulation; Forkhead | 2014 |
[Cardiovascular complications of desoxycorticosterone acetate and vitamin C in therapeutic doses].
Topics: Adrenal Cortex Hormones; Ascorbic Acid; Cardiovascular System; Desoxycorticosterone Acetate; Heart D | 1951 |